𝔖 Bobbio Scriptorium
✦   LIBER   ✦

638 Seronegative autoimmune hepatitis in patients with cryptogenic liver disease — absence of exogenous viral sequences in cryptogenic liver disease

✍ Scribed by S. Heringlake; A. Schüttee; A. Sauere; G. Hunsmann; W. Schmiegel; M. Mannss

Book ID
117374914
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
138 KB
Volume
44
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis G virus in patients with crypt
Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation
✍ M G Pessoa; N A Terrault; L D Ferrell; J P Kim; J Kolberg; J Detmer; M L Collins 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

To examine the prevalence of hepatitis G virus (HGV) in end-stage liver disease of unknown cause and the role of HGV infection in posttransplantation hepatitis, we studied 46 patients undergoing liver transplantation (mean age, 50 years; M:F, 18:28) with cryptogenic cirrhosis. HGV RNA was detected b

Occult hepatitis C virus infection in Ir
Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease
✍ Farah Bokharaei-Salim; Hossein Keyvani; Seyed Hamid Reza Monavari; Seyed Moayed 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Abstract The diagnosis of cryptogenic liver disease is made when after extensive evaluations, recognizable etiologies of chronic liver disease are excluded. In this study, the presence of hepatitis C virus (HCV) RNA was tested in peripheral blood mononuclear cells (PBMCs) taken from Iranian pati

Seroprevalence of hepatitis C virus nucl
Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease
✍ Dr. Jonathan Brown; Spyros Dourakis; Peter Karayiannis; Robert Goldin; Joe Chiba 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

The serological responses to two different hepatitis C virus antigens were studied by enzyme-linked immunosorbent assay in a variety of chronic liver diseases and in healthy blood donors. The study population comprised 97 cases of cryptogenic chronic liver disease (40% with a history suggestive of p